Entering text into the input field will update the search result below

Sarepta rallies as Piper upbeat on eteplirsen NDA

Oct. 04, 2013 12:25 PM ETSarepta Therapeutics, Inc. (SRPT) StockSRPT, RNA-OLDBy: Colin Lokey, SA News Editor
  • Sarepta Therapeutics (SRPT +4.9%) is on the move, and with today's gains the shares are up some 10% since Wednesday when disappointing dystrophin production data from Prosensa's (NASDAQ:RNA) drisapersen boosted sentiment around eteplirsen.
  • Today's catalyst appears to be a note out of Piper which emphasizes eteplirsen's safety profile.
  • SRPT is now up more than 50% since the end of August.

Recommended For You

More Trending News

About SRPT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SRPT--
Sarepta Therapeutics, Inc.